The experimental results of an in situ tumor-bearing mouse model showed that after PD-1 inhibitor therapy combined with radiotherapy, the ratio of CD4+/CD8+ T cells, neutrophils, IFN-γ, TNF, and IL-5 in the lung tissue of the mouse model increased, and inflammatory reactions increased [218]. The gene discussed is PDCD1; the disease is neoplasm.